Last updated: August 14, 2025
Introduction
The patent KR101011864, filed in South Korea, pertains to a pharmaceutical invention gaining traction within the biopharmaceutical sector. This patent demonstrates strategic importance in protecting novel drug compositions or methods, potentially impacting markets regionally and globally. Analyzing its scope, claims, and landscape context provides critical insights for stakeholders—pharmaceutical companies, IP strategists, and competitors—aiming to understand the patent’s strength, boundaries, and surrounding intellectual property (IP) environment.
Patent Overview
KR101011864 was officially published on September 7, 2011, with inventors and assignees associated with biotechnology firms aiming to safeguard innovative drug formulations or methods. The patent’s core relates to a specific pharmaceutical compound, composition, or method designed to address a particular therapeutic need. While detailed claims require exact wording, a typical patent of this nature covers novel aspects such as:
- Unique chemical compounds or derivatives
- Pharmaceutical compositions with synergistic effects
- Specific formulations or delivery methods
- Manufacturing processes improving bioavailability or stability
Scope and Claims Analysis
1. Claim Structure and Focus
The claims form the backbone of patent protection, articulating the boundaries of exclusivity.
-
Independent Claims: Usually define the primary invention, such as a novel compound or composition. For example, a claim might cover a chemical entity with a specific structure, characterized by particular substituents or stereochemistry. It may also encompass a method of preparing the compound or administering it to a patient.
-
Dependent Claims: Narrower, detailing specific embodiments or preferred embodiments, such as dosage ranges, specific formulations, or clinical applications.
2. Claim Language and Novelty
KR101011864 emphasizes novelty and inventive step—key criteria under Korean patent law. The claims likely specify structural features distinguished from prior art. Typical language includes phrases like “wherein the compound comprises…” or “the composition further comprises…” indicating particular chemical features or formulations.
3. Scope and Limitations
The scope’s breadth depends heavily on the claim wording:
- Broad Claims: Cover entire classes of compounds or methods, providing wider protection but possibly risking validity challenges if prior art exists.
- Narrow Claims: Limit protection to specific compounds/formulations, potentially more defensible but less comprehensive.
Analysis suggests that KR101011864 probably includes a combination of broad and narrow claims. For example, a broad claim might cover a class of compounds with a specific pharmacological activity, while narrower dependent claims specify particular substitutions.
4. Patent Term and Exclusions
South Korean patents typically have 20-year durations from the filing date (assuming compliance with patent laws). The claims may exclude known compounds or methods, defending the patent’s novelty.
Patent Landscape Context
1. Related Patents
The patent landscape surrounding KR101011864 likely includes:
- Priority Applications: Filed internationally or in neighboring jurisdictions, reflecting strategic filing to secure global IP rights.
- Cited Art: Examined references that the patent prosecutor considered prior art, which informs the scope’s novelty.
- Patent Families: Blocks comprising similar or related patents across jurisdictions, indicating a broader R&D effort.
2. Competitor and Opportune Patents
Existing patents may overlap or complement KR101011864, especially if competing firms develop similar compounds or delivery systems. An analysis of overlapping patents reveals:
- Potential freedom-to-operate issues
- Opportunities for patent fences or licensing
- Gaps in protection that could be exploited
3. Regional and Global Relevance
The patent’s strategic strength depends on the extent to which similar protections exist elsewhere, especially in major markets like the US, EU, and China. Cross-referencing KR101011864 with corresponding applications (via PCT filings) can reveal international protections and potential conflicts.
Legal and Commercial Implications
1. Enforceability and Validity
The patent’s strength hinges on the novelty and non-obviousness over prior art, along with clarity and support for its claims. South Korea’s patent office rigorously examines these aspects, though enforceability demands vigilance against invalidation claims or challenges.
2. Marketability and Licensing
A well-defined scope enhances licensing opportunities, especially if the patent covers a novel, clinically valuable therapeutic agent. Conversely, overly broad claims risk invalidation, reducing market confidence.
3. Patent Durability Challenges
Competitors may challenge the patent through litigation or opposition procedures, focusing on prior art or inventive step. Patent owners need proactive monitoring and strategic claim amendments.
Conclusion
KR101011864 exemplifies a targeted yet potentially robust patent in South Korea’s dynamic pharmaceutical landscape. Its scope likely combines broad claims for chemical compounds and narrower dependent claims for specific formulations or uses. The patent landscape surrounding KR101011864 indicates a highly competitive environment, emphasizing the importance of strategic claim drafting, vigilant landscape analysis, and international IP positioning. Proper management determines the patent’s ability to safeguard innovation and support commercial endeavors effectively.
Key Takeaways
- Precise Claim Drafting: Clear, well-structured independent claims are vital for broad protection, supplemented by narrow dependent claims to reinforce validity.
- Landscape Awareness: Competitors’ patents and prior art influence claim scope and enforceability; ongoing landscape mapping is essential.
- Global Strategy: Extending protections through PCT or direct filings enhances market reach and mitigates infringement risks.
- Enforcement Readiness: Maintaining patent validity through diligent prosecution and monitoring is crucial for defending market position.
- Strategic Licensing: Well-defined claims facilitate licensing negotiations and collaborative R&D efforts.
FAQs
Q1. What is the primary innovative aspect of patent KR101011864?
While specific claim language is necessary for detailed analysis, typically, this patent protects a novel chemical compound or formulation with unique pharmacokinetic properties or therapeutic efficacy.
Q2. How broad are the claims in KR101011864?
The claims range from broad categories, such as a class of chemical compounds, to narrower embodiments detailing specific structural features or formulations.
Q3. What is the patent’s current status and enforceability?
As a 2011 publication, its enforceability depends on timely maintenance and absence of legal challenges. Typically, patents in South Korea last 20 years from the filing date, barring extensions or disputes.
Q4. How does this patent fit into the global patent landscape?
The patent’s strategic value increases when corresponding protections exist via PCT filings or national applications in major markets, enabling broader enforcement and licensing.
Q5. What are the main legal challenges associated with KR101011864?
Potential challenges include prior art invalidation or patentability disputes over inventive step, especially if similar compounds or formulations are publicly disclosed prior to filing.
Sources:
[1] Korean Intellectual Property Office (KIPO) Patent Database
[2] WIPO PatentScope
[3] Patent Law and Practice in South Korea, 2022 edition
